Chantal Combredet
0000-0002-2161-199X
Publication & Citation Trends
Publications
0 total
Disabling a key viral innate immunity antagonist converts measles vaccine into RIG-I–driven cancer immunotherapy
Cited by 0
Semantic Scholar
Induction of tissue resident memory T cells by measles vaccine vector OA
Cited by 0
Semantic Scholar
Interplay between oncolytic measles virus, macrophages and cancer cells induces a proinflammatory tumor microenvironment OA
Cited by 8
Semantic Scholar
Applying Reverse Genetics to Study Measles Virus Interactions with the Host.
Cited by 1
Semantic Scholar
Antagonism of ALAS1 by the Measles Virus V protein contributes to degradation of the mitochondrial network and promotes interferon response OA
Cited by 6
Semantic Scholar
Oncolytic attenuated measles virus encoding NY-ESO-1 induces HLA I and II presentation of this tumor antigen by melanoma and dendritic cells OA
Cited by 2
Semantic Scholar
1315 MVdeltaC, a new therapeutic vaccine demonstrates promising preclinical immuno-oncolytic activities OA
Cited by 0
Semantic Scholar
Research Topics
Virology and Viral Diseases
(53)
vaccines and immunoinformatics approaches
(33)
Virus-based gene therapy research
(23)
Immunotherapy and Immune Responses
(18)
Microbial infections and disease research
(14)
Affiliations
Centre National de la Recherche Scientifique
Inserm
Institut Pasteur
Université Paris Cité
Global Viral